Table 5.
Time-to-death adjustment (six months) | Exclusion of cases of mortality (six months prior to death) | EQ-5DIndex = 0 in month of death | ||||
---|---|---|---|---|---|---|
(1) | (2) | (3) | (4) | (5) | (6) | |
EQ-5DIndex | EQ-5DIndex | EQ-5DIndex | EQ-5DIndex | EQ-5DIndex | EQ-5DIndex | |
Value at baseline | 0.348*** | 0.346*** | 0.333*** | 0.331*** | 0.333*** | 0.331*** |
ASB life threatening/disabling | −0.0593 | −0.140* | 0.0356 | −0.0497 | −0.0599 | −0.121 |
…at the second follow-up after event | −0.145* | −0.155* | −0.0993 | |||
…at the third follow-up after event | −0.163** | −0.0950 | −0.145* | |||
NASB life threatening/disabling | −0.449*** | −0.493*** | −0.457*** | −0.508*** | −0.448*** | −0.465*** |
…at the second follow-up after event | −0.114 | −0.140 | −0.101 | |||
…at the third follow-up after event | 0.103 | 0.0936 | 0.109 | |||
Stroke / TIA | −0.147* | −0.206** | −0.145* | −0.210** | −0.147* | −0.199* |
…at the second follow-up after event | −0.123 | −0.146* | −0.121 | |||
…at the third follow-up after event | −0.0319 | −0.0286 | −0.0307 | |||
AKIN 2 | −0.167* | −0.226** | −0.267** | −0.270** | −0.169* | −0.272** |
…at the second follow-up after event | −0.142 | −0.0428 | −0.195* | |||
…at the third follow-up after event | 0.0657 | 0.0150 | 0.0508 | |||
AKIN 3 | −0.173** | −0.186** | −0.235** | −0.293*** | −0.381*** | −0.418*** |
…at the second follow-up after event | −0.113 | −0.177* | −0.235** | |||
…at the third follow-up after event | −0.00684 | −0.0338 | −0.0939 | |||
Other complications | 0.00548 | 0.00571 | 0.0134 | 0.0140 | 0.00464 | 0.00368 |
Last follow-up before death | −0.493*** | −0.487*** | ||||
Second last follow-up before death | −0.275*** | −0.272*** | ||||
Third from last follow-up before death | −0.210*** | −0.217*** | ||||
Fourth from last follow-up before death | −0.180*** | −0.189*** | ||||
Fifth from last follow-up before death | −0.154*** | −0.166*** | ||||
Sixth from last follow-up before death | −0.108** | −0.116** | ||||
Overall trend | −0.00161 | −0.00222** | −0.00195* | −0.00249** | −0.00322*** | −0.00386*** |
Month 1 post-discharge | −0.0230 | −0.0283 | −0.0256 | −0.0301 | −0.0163 | −0.0218 |
Constant | 0.529*** | 0.543*** | 0.548*** | 0.559*** | 0.508*** | 0.523*** |
N | 2212 | 2212 | 2102 | 2102 | 2250 | 2250 |
* p < 0.05, ** p < 0.01, *** p < 0.001
The EQ-5DIndex is a continuous variable between 0 and 1 (0 = worst state, 1 = best state). ASB access site bleeding, NASB non-Access Site Bleeding, VASC vascular complication, AKIN acute kidney injury. Please note that we also increased these time lags up to 6 months after complications but found no additional effects